Julie Person
Verwaltungsdirektor bei THIRD HARMONIC BIO, INC.
Vermögen: - $ am 30.04.2024
Profil
Julie Person is currently the Chief Administrative Officer at Third Harmonic Bio, Inc. She previously worked as the Vice President-Human Resources at Sangamo Therapeutics, Inc. from 2019 to 2020.
She also held the position of Head-Human Resources at Astellas Gene Therapies, Inc. Additionally, Julie served as the Chief People Officer at Neumora Therapeutics, Inc. from 2021 to 2022.
Prior to that, she was the VP-Talent Management & Organizational Development at Shire Plc from 2017 to 2019.
Ms. Person completed her undergraduate degree at St. Mary's College of California.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
THIRD HARMONIC BIO, INC.
-.--% | 04.04.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Julie Person
| Unternehmen | Position | Beginn |
|---|---|---|
| THIRD HARMONIC BIO, INC. | Verwaltungsdirektor | 01.06.2022 |
Ehemalige bekannte Positionen von Julie Person
| Unternehmen | Position | Ende |
|---|---|---|
| NEUMORA THERAPEUTICS, INC. | Personalreferent | 01.06.2022 |
| SANGAMO THERAPEUTICS, INC. | Personalreferent | 01.04.2020 |
| SHIRE | Personalreferent | 01.03.2019 |
| AUDENTES THERAPEUTICS, INC. | Personalreferent | - |
Ausbildung von Julie Person
| St. Mary's College of California | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| THIRD HARMONIC BIO, INC. | Health Technology |
| NEUMORA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
Astellas Gene Therapies, Inc.
 Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Astellas Gene Therapies, Inc. is a biotechnology company, which engages in the development and commercialization of gene therapy products for patients with serious and rare diseases caused by single gene defects. The company was founded by Matthew R. Patterson and Thomas J. Schuetz on November 13, 2012 and is headquartered in San Francisco, CA. | Health Technology |
